Calcitonin receptor (CTR) is a class B G protein-coupled receptor (GPCR) that regulates calcium homeostasis and bone turnover upon activation by calcitonin and is an osteoporosis drug target (Lee et al., 2020). Here, CALCA is linked to osteoporosis.